CVS Health is suing the federal government to challenge its 2027 Medicare Advantage star ratings, aiming to avert a potential revenue loss exceeding $2 billion due to declining quality scores. The lawsuit argues that the CMS used illegal methodology and improperly adopted measures to calculate the ratings. CVS joins at least four other insurers in similar lawsuits, all citing a previous ruling that found CMS measures for 2026 scores to be illegal.
Original sourceCENTENE CORP
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$68.45
-0.25%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+12.2%
3 months
+7.4%
6 months
+28.3%
1 year
+95.5%
Year to date
+66.3%
52-week range
$31.80 – $71.24
Fundamental snapshot
Latest reported period: Sep 30, 2026
Market cap
$33.89B
P/E
23.2
P/B
1.5
P/S
0.2
Revenue
$203.9B
Net income
$1.46B
Diluted EPS
2.92
Gross margin
7.80%
Net margin
0.70%
Return on equity
6.80%
Total debt
$15.54B
Cash
$20.7B
Free cash flow
$3.94B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $50.65B | -$71M | 6.40% | -0.10% | -$3.86B |
| Jun 30, 2026 | $53.58B | $1.09B | 8.60% | 2.00% | $3.42B |
| Mar 31, 2026 | $49.94B | $1.54B | 11.10% | 3.10% | $4.17B |
| Dec 31, 2025 | $49.73B | -$1.1B | 5.00% | -2.20% | $224M |
| Sep 30, 2025 | $49.69B | -$6.63B | 6.50% | -13.30% | $1.15B |
| Jun 30, 2025 | $48.74B | -$253M | 6.00% | -0.50% | $1.58B |
| Mar 31, 2025 | $46.62B | $1.31B | 11.20% | 2.80% | $1.38B |
| Dec 31, 2024 | $40.81B | $283M | 9.10% | 0.70% | -$741M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CNC news
All market newsAfter a buoyant third quarter, Centene now thinks its Medicare business will break even one year ahead of schedule. Staffing cuts saddled the insurer with severance spending, but should help margins in 2027.
Original sourceThe St. Louis-based insurer is adding onto a growing pile of lawsuits from insurers trying to get their quality scores recalculated — and nab hundreds of millions of dollars in extra payments as a result.
Original source